SCHEMBL30827642

SCHEMBL30827642

Cc1ccc(N)c(Nc2ccc(Cl)nc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.52
▸ PIK3CA P42336 6/20 0.49
▸ GRM4 Q14833 1/20 0.41
▸ SRC P12931 1/20 0.39
▸ KCNQ3 O43525 2/20 0.37
▸ KCNQ2 O43526 2/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ KCNQ1 P51787 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK7 P50613 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CCNH P51946 1/20 0.37
▸ GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27252315 1.00 TNF (0.52) TNFPIK3CAGRM4SRCKCNQ3
SCHEMBL27252312 0.77 TNF (0.48) TNFPIK3CAGRM4SRCKCNQ3
SCHEMBL12727110 0.77 RAB9A (0.47) RAB9AAHRSMN1; SMN2KMT2ANPC1
SCHEMBL27252314 0.76 TNF (0.50) TNFPIK3CAGRM4SRCKCNQ3
SCHEMBL30827602 0.76 TNF (0.47) TNFPIK3CARAB9AKMT2ANPC1
SCHEMBL29310766 0.76 TNF (0.47) TNFPIK3CARAB9AKMT2ANPC1
SCHEMBL23927057 0.75 PIK3CA (0.57) TNFPIK3CAGRM4KCNQ3KCNQ2
SCHEMBL30079596 0.75 PIK3CA (0.57) TNFPIK3CAGRM4KCNQ3KCNQ2
SCHEMBL1600224 0.74 MAPT (0.43) RAB9ANR1I2AHRSMN1; SMN2KMT2A
SCHEMBL13506395 0.74 CYP1A2 (0.49) RAB9AKMT2ABCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4590397-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2025-07-30 — — EP disclosed
WO-2024062090-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2024-03-28 — — WO disclosed
Send feedback